UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities:
Net income (loss)	$ 69,063	$ 615
(Loss) income from discontinued operations, net of income taxes	75,379	3,270
Loss from continuing operations, net of income taxes	(6,316)	(2,655)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization	3,981	2,980
Amortization of intangibles	1,757	1,638
Amortization of deferred financing costs	576	503
Change in deferred income tax	1,404	(167)
Compensation under stock-based compensation plans	2,711	2,252
Loss on disposal of fixed assets	45	64
Changes in assets and liabilities, net of acquired business:
Receivables, net of bad debt expense	78,925	(7,905)
Inventory	(3,104)	2,337
Prepaid expenses and other assets	4,769	(63)
Accounts payable	(50,313)	(803)
Claims payable	(860)	2,161
Amounts due to plan sponsors	462	4,062
Accrued expenses and other liabilities	8,797	5,144
Net cash provided by (used in) operating activities from continuing operations	42,834	9,548
Net cash provided by operating activities from discontinued operations	(21,195)	28,950
Net cash provided by operating activities	21,639	38,498
Cash flows from investing activities:
Purchases of property and equipment, net	(3,682)	(4,422)
Cash consideration paid for acquisitions, net of cash acquired	(466)	0
Cash consideration paid to DS Pharmacy	(2,935)	0
Cash consideration paid for unconsolidated joint ventures, net of cash acquired	(7,100)	0
Net cash used in investing activities from continuing operations	(14,183)	(4,422)
Net cash provided by (used in) investing activities from discontinued operations	161,499	(1,447)
Net cash used in investing activities	147,316	(5,869)
Cash flows from financing activities:
Borrowings on line of credit	848,633	841,200
Repayments on line of credit	(882,455)	(874,301)
Repayments of capital leases	(2,211)	(59)
Deferred and other financing costs	0	(22)
Net proceeds from exercise of employee stock compensation plans	5,675	691
Surrender of stock to satisfy minimum tax withholding	(174)	(138)
Net cash (used in) provided by financing activities	(30,532)	(32,629)
Net change in cash and cash equivalents	138,423	0
Cash and cash equivalents - end of period	0	0
Cash and cash equivalents - end of period	138,423	0
DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	13,641	14,020
Cash paid during the period for income taxes, net of refunds	313	682
Capital lease obligations incurred to acquire property and equipment	$ 20	$ 0